×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Koppel Adam

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
SLDBSolid Biosciences Inc.Koppel AdamDirectorJan 11, 2024Option Exercise$5.53904,1605,000,0054,034,582Jan 12, 2024, 04:56 PM
CERECerevel Therapeutics Holdings, Inc.Koppel AdamDirectorOct 16, 2023Buy$22.815,480,052124,999,98365,679,781Oct 18, 2023, 04:30 PM
DRNADicerna Pharmaceuticals IncKoppel AdamDirectorDec 28, 2021Option Exercise$38.253,333127,4870Dec 29, 2021, 04:43 PM
DRNADicerna Pharmaceuticals IncKoppel AdamDirectorDec 28, 2021Option Exercise$38.253,080,237117,819,0650Dec 29, 2021, 04:43 PM
SWTXSpringWorks Therapeutics, Inc.Koppel Adam10% OwnerAug 10, 2021Sale$70.251,000,00070,250,0004,831,307Aug 12, 2021, 08:38 PM
RPIDRAPID MICRO BIOSYSTEMS, INC.Koppel Adam10% OwnerJul 19, 2021Buy$20.00100,0002,000,0008,434,560Jul 21, 2021, 04:40 PM
SLDBSolid Biosciences Inc.Koppel AdamDirectorMar 23, 2021Option Exercise$5.75869,5654,999,9997,929,918Mar 25, 2021, 04:30 PM
SWTXSpringWorks Therapeutics, Inc.Koppel Adam10% OwnerMar 09, 2021Sale$71.501,450,000103,675,0005,831,307Mar 11, 2021, 04:30 PM
DRNADicerna Pharmaceuticals IncKoppel AdamDirectorDec 10, 2020Sale$23.401,000,00023,400,0003,080,237Dec 14, 2020, 05:35 PM
SLDBSolid Biosciences Inc.Koppel AdamDirectorDec 10, 2020Option Exercise$3.703,189,18911,799,9997,060,353Dec 11, 2020, 04:30 PM
CERECerevel Therapeutics Holdings, Inc.Koppel AdamDirectorNov 09, 2020Buy$10.30332,2933,422,61860,632,356Nov 12, 2020, 05:54 PM
CERECerevel Therapeutics Holdings, Inc.Koppel AdamDirectorOct 27, 2020Buy$10.0010,000,000100,000,00060,300,063Oct 29, 2020, 08:00 PM
APTXAptinyx Inc.Koppel AdamDirectorOct 26, 2020Buy$3.003,333,3339,999,9998,891,758Oct 27, 2020, 05:07 PM
BLSABCLS Acquisition Corp.Koppel AdamDirectorOct 26, 2020Option Exercise$10.00487,5004,875,000487,500Oct 26, 2020, 04:30 PM
ANNXAnnexon, Inc.Koppel Adam10% OwnerJul 28, 2020Buy$17.00400,0006,800,0003,241,628Jul 28, 2020, 04:45 PM
ARQTArcutis Biotherapeutics, Inc.Koppel Adam10% OwnerFeb 04, 2020Buy$17.00294,1174,999,9893,979,292Feb 06, 2020, 04:26 PM
APTXAptinyx Inc.Koppel AdamDirectorJan 14, 2020Buy$3.003,333,3339,999,9995,558,425Jan 16, 2020, 04:20 PM
DRNADicerna Pharmaceuticals IncKoppel AdamDirectorDec 04, 2019Sale$24.681,500,00037,020,0004,080,237Dec 06, 2019, 05:00 PM
DRNADicerna Pharmaceuticals IncKoppel AdamDirectorNov 19, 2019Sale$22.031,750,00038,552,5015,580,237Nov 21, 2019, 04:26 PM
SWTXSpringWorks Therapeutics, Inc.Koppel Adam10% OwnerSep 17, 2019Buy$18.00150,0002,700,0007,281,307Sep 19, 2019, 07:05 PM
SLDBSolid Biosciences Inc.Koppel AdamDirectorJul 30, 2019Option Exercise$4.651,881,7208,749,9983,871,164Jul 30, 2019, 04:37 PM
DRNADicerna Pharmaceuticals IncKoppel AdamDirectorMay 29, 2019Sale$12.501,600,00020,000,0007,330,237May 31, 2019, 04:15 PM
REPLReplimune Group, Inc.Koppel AdamDirectorJul 24, 2018Buy$15.00500,0007,500,0002,838,968Jul 26, 2018, 04:27 PM
APTXAptinyx Inc.Koppel AdamDirectorJun 25, 2018Buy$16.00400,0006,400,0002,225,092Jun 26, 2018, 04:50 PM
SLDBSolid Biosciences Inc.Koppel AdamDirectorJan 30, 2018Buy$16.00300,0004,800,0001,989,444Feb 01, 2018, 07:07 PM
MRNSMARINUS PHARMACEUTICALS INCKoppel Adam10% OwnerDec 19, 2017Sale$7.43150,0001,114,6704,032,682Dec 19, 2017, 08:30 PM
MRNSMARINUS PHARMACEUTICALS INCKoppel Adam10% OwnerDec 15, 2017Sale$8.10822,5476,658,6914,530,335Dec 19, 2017, 08:30 PM
MRNSMARINUS PHARMACEUTICALS INCKoppel Adam10% OwnerDec 18, 2017Sale$7.50300,0002,251,4404,127,453Dec 19, 2017, 08:30 PM
DRNADicerna Pharmaceuticals IncKoppel AdamDirectorDec 18, 2017Buy$7.00285,0001,995,000285,000Dec 19, 2017, 04:52 PM
BIIBBIOGEN INC.Koppel AdamEVP, Strategy and Bus. Dev.Jun 06, 2016Sale$290.00555160,9502,402Jun 07, 2016, 04:09 PM
BIIBBIOGEN INC.Koppel AdamEVP, Strategy and Bus. Dev.Jun 02, 2016Option Exercise$289.73534154,7162,957Jun 06, 2016, 08:48 PM
BIIBBIOGEN INC.Koppel AdamEVP, Strategy and Bus. Dev.Apr 06, 2016Sale$275.0010228,0501,848Apr 07, 2016, 05:03 PM
BIIBBIOGEN INC.Koppel AdamEVP, Strategy and Bus. Dev.Feb 23, 2016Option Exercise$258.999825,3811,865Feb 25, 2016, 05:02 PM
BIIBBIOGEN INC.Koppel AdamSVP, Chief Strategy OfficerJun 02, 2015Option Exercise$387.62852330,2521,662Jun 04, 2015, 05:49 PM
PTCTPTC THERAPEUTICS, INC.Koppel AdamDirectorJun 25, 2013Buy$15.001,250,00018,750,0002,333,333Jun 28, 2013, 05:52 PM